Proacta Company
Proacta is a clinical-stage biopharmaceutical company developing hypoxia-activated ’prodrugs“ for the treatment of cancer.
Number Of Exists:
N/A
Technology:
Others
Last Funding Type:
Debt Financing
Investors Number:
7
Industry:
PharmTech
Founded Date:
2004
Investor Type:
N/A
Employee Number:
1-10
Investment Stage:
N/A
Total Funding:
$47M
Headquarters:
La Jolla, California, United States
Funding Status:
Early Stage Venture